Eye drops 20% in the form of a clear, colorless or slightly colored liquid.
Antimicrobial agent – sulfonamide.
In the complex treatment of diseases of the eyelids, conjunctiva, cornea, anterior segment of the choroid and lacrimal ducts, caused by microorganisms sensitive to sulfacetamide.
For the prevention of infectious complications in the treatment of burns and injuries of the organ of vision.
Individual hypersensitivity to the components of the drug, children (up to 2 months).
Use during pregnancy and lactation
The use of the drug during pregnancy is only possible if the intended benefit to the mother outweighs the potential risk to the fetus. You should refrain from breast-feeding during the period of use of the drug due to the lack of relevant clinical data.
Perhaps the development of nuclear jaundice in newborns whose mothers took the tablet form of sulfanilamides during pregnancy, so it is impossible to exclude the risk of jaundice when taking sulfanilamide in the dosage form eye drops.
Patients with hypersensitivity to furosemide, thiazide diuretics, sulfonylurea or carbonic anhydrase inhibitors may have an increased sensitivity to sulfacetamide.
Possible excessive growth of microorganisms insensitive to sulfonamide, as well as fungal flora.
Decreased antibacterial activity of sulfonamides in the presence of high concentrations of naraaminobenzoic acid in the presence of a large amount of purulent discharge.
It is necessary to stop sulfanilamide therapy in case of allergy symptoms, as well as with increased pain and other signs of an infectious inflammatory process, an increase in the amount of purulent discharge.
Impact on the ability to drive transp. Wed and fur.: In case of blurred vision after installation, it is necessary to refrain from driving vehicles and engaging in potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions until the vision is restored.
1 ml of sodium sulfacetamide monohydrate (in terms of sodium sulfacetamide) 200 mg
sodium thiosulfate 1 penta solution 1 penta water d / i – up to 1 ml.
Dosage and administration
1-2 drops in the conjunctival sac 6-8 times a day (every 2-3 hours). The course of treatment is 7-10 days. The number of installations can be reduced as the condition improves.
When treating diseases of the organ of vision caused by Chlamydia trachomatis, the dosage regimen is 1 drop every 2 hours, topical application of sulfonamide must be combined with systemic therapy.
Allergic reactions, burning, lacrimation, throat, itching in the eyes, transient blurred vision after instillation, nonspecific conjunctivitis, development of superinfection, severe allergic reactions to sulfonamides (Steven-Johnson syndrome, toxic epidermolysis, fulminant liver necrosis, agranulocytosis, aplastic anemia).
If any of the side effects indicated in the instructions are aggravated or you notice any other side effects not listed in the instructions, inform your doctor.
Sulfacetamide enhances the effect of indirect anticoagulants. Joint use with procaine. tetracaine benzocaine reduces the bacteriostatic effect of sulfacetamide.
Diphenin, para-aminosalicylic acid (PASK), salicylates increase its toxicity. Incompatible with silver salts.
Cases of overdose of the drug are not described.
Terms and conditions
Grotteks pf860860819 oteks Ltd., Russia